AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 259 filers reported holding AMICUS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $742 | -52.3% | 61 | -50.8% | 0.00% | – |
| Q2 2023 | $1,557 | -39.7% | 124 | -46.8% | 0.00% | – |
| Q1 2023 | $2,584 | -99.9% | 233 | -99.9% | 0.00% | -100.0% |
| Q4 2021 | $2,624,000 | -70.8% | 227,192 | -41.6% | 0.01% | -72.2% |
| Q4 2020 | $8,978,000 | +336.2% | 388,812 | +166.7% | 0.02% | +260.0% |
| Q3 2020 | $2,058,000 | -5.8% | 145,765 | +0.6% | 0.01% | 0.0% |
| Q2 2020 | $2,184,000 | +18100.0% | 144,858 | +16512.2% | 0.01% | – |
| Q1 2019 | $12,000 | +33.3% | 872 | -8.1% | 0.00% | – |
| Q4 2018 | $9,000 | -50.0% | 949 | -33.4% | 0.00% | – |
| Q3 2018 | $18,000 | -98.8% | 1,424 | -98.5% | 0.00% | -100.0% |
| Q2 2018 | $1,531,000 | +13818.2% | 98,031 | +13402.9% | 0.00% | – |
| Q1 2018 | $11,000 | -98.8% | 726 | -98.9% | 0.00% | -100.0% |
| Q4 2017 | $934,000 | -71.8% | 64,921 | -70.5% | 0.00% | -70.0% |
| Q3 2017 | $3,315,000 | – | 219,833 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |